PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Paper sensors and smartphone app monitor personal smoke exposure

2025-05-07
(Press-News.org) An inexpensive paper sensor along with a smartphone-based reader developed by a Washington State University-led team can rapidly provide information on a person’s personal smoke exposure during wildfire season.

The sensor can provide valuable information for firefighters and others to clarify just how much harmful pollution they might inhale during smoky conditions. The researchers, including from University of Washington and University of Georgia, report on their work in the journal, ACS Applied Materials and Interfaces.

The paper biosensor uses tiny, flower-like particles of palladium and platinum to detect and amplify the signal from wildfire smoke biomarkers in urine. To make the system field-ready, the team also developed a custom 3D-printed smartphone reader and app, allowing users to rapidly scan and quantify their exposure on-site.

“Our goal is to quickly identify the exposure onsite in real time and report it with a smartphone reader, so agencies can quickly identify the exposure level and location and make decisions for a hazard prevention strategy,” said Annie Du, a research professor in WSU’s School of Mechanical and Materials Engineering who is leading the project.

With the increasing number and size of wildfires in recent years, researchers would like better information on people’s personal smoke exposure to understand and mitigate its health impacts more effectively. Human exposure to wood smoke is linked to numerous health issues, including respiratory disease, cardiovascular disease, and lung cancer.

Currently, estimates of a person’s smoke exposure level are not exact. Agencies determine how much smoke a person may be exposed to based on computer models that use regional meteorology, satellite data, air quality sensors in the region, or even personal perceptions of smoke levels. Those methods sometimes miss the big variations in smoke that can happen in a small area. They also don’t get a person’s specific exposure levels to chemicals or how a person might variably metabolize and process pollutants in his or her body.

Furthermore, exposure to pollutants from wildfires could have impacts on people – even if they don’t have a lot of symptoms.

“You’re exposed to smoke when you breathe in the polluted air, but your body changes that to a metabolite and introduces changes to your DNA,” said Du, who is also in the College of Pharmacy and Pharmaceutical Sciences. “That’s why we are focused on early detection -- We want to catch biological changes before clinical symptoms appear.”

There are blood tests to measure smoke exposure, but they’re cumbersome and expensive, requiring that samples be sent to a laboratory for analysis. When fires are in remote areas, getting information on a person’s exposure is even more difficult.

With the test strips, the researchers were able to measure tiny amounts of metabolites from the pollutant benzene.  Their biosensor device is low-cost and very sensitive to the signal of the benzene metabolites.

Unlike a COVID test strip, which only determines whether or not a person has COVID, their sensor can quantify the amount of harmful chemicals someone has been exposed to. The 3D-printed sensor can be connected to a smartphone, so that using a phone’s location data, researchers can determine exactly where smoke levels are most hazardous and identify the chemicals present in different neighborhoods.

The researchers have tested the strips in a lab setting. They will now begin testing the strips with firefighters during the wildfire season and comparing them to standard lab tests. While they will initially test with wildland firefighters, they are working with WSU’s Office of Commercialization and plan to adapt and expand the technology to other vulnerable populations in the future. The work was funded by the Centers for Disease Control and Prevention.

END


ELSE PRESS RELEASES FROM THIS DATE:

Immunogenicity and safety of influenza and COVID-19 multicomponent vaccine in adults age 50 and older

2025-05-07
About The Study: In this phase 3 study, mRNA-1083, an investigational, multicomponent vaccine against seasonal influenza and SARS-CoV-2, met noninferiority criteria and induced higher immune responses than recommended standard care influenza (standard and high dose) and COVID-19 vaccines against all 4 influenza strains (among those ages 50-64), the 3 clinically relevant influenza strains (among those age 65 and older), and SARS-CoV-2 (all ages), with an acceptable tolerability and safety profile. Corresponding Author: To contact the corresponding author, Amanda K. Rudman Spergel, MD, email Amanda.RudmanSpergel@modernatx.com. To ...

Comb jellies reveal ancient origins of animal genome regulation

2025-05-07
Life depends on genes being switched on and off at exactly the right time. Even the simplest living organisms do this, but usually over short distances across the DNA sequence, with the on/off switch typically right next to a gene. This basic form of genomic regulation is probably as old as life on Earth.  A new study published today in Nature by researchers at the Centre for Genomic Regulation (CRG) and the Centre Nacional d’Anàlisi Genòmica (CNAG) finds that the ability to control genes from far away, over many tens of thousands of DNA letters, evolved between 650 and 700 million years ...

Will you live an unprecedented life?

2025-05-07
Climate change's disproportionate burden on youth  Climate extremes, including heatwaves, crop failures, river floods, tropical cyclones, wildfires and droughts, will intensify with continued atmospheric warming. Today’s children will endure more climate extremes then any previous generation.   “In 2021, we demonstrated how children are to face disproportionate increases in extreme event exposure – especially in low-income countries. Now, we examined where the cumulative exposure to climate extremes across one’s lifetime will far exceed that which would have ...

Study finds teens driving older vehicles have increased risk for fatal crashes

2025-05-07
(COLUMBUS, Ohio) – Motor vehicle crashes are the leading cause of death for U.S. teens. Newer vehicles and driver assistance technologies show promise in reducing crashes and injury severities.  Researchers at Nationwide Children’s Hospital reviewed national fatal crash data (2016-2021) and examined the vehicle age and driver assistance technologies of vehicles driven by teen and middle-aged drivers, and their associations with driver deaths during fatal crashes.  In a study published today ...

AI Model Improves Delirium Prediction, Leading to Better Health Outcomes for Hospitalized Patients

2025-05-07
New York, NY [May 7, 2025]—An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and alerts a specially-trained team to assess the patient and create a treatment plan, if needed. The model, developed by researchers at the Icahn School of Medicine at Mount Sinai, has been integrated into hospital operations, helping health care providers identify and manage delirium, a condition that can affect up to one-third of hospitalized ...

Vehicle age and driver assistance technologies in fatal crashes involving teen and middle-aged drivers

2025-05-07
About The Study: The findings of this study suggest that older vehicles and those with fewer driver assistance technologies are associated with increased risk of driver death in fatal crashes; thus, teens should drive the safest vehicles available, not older family cars. The findings underscore the urgent need to ensure teens drive safer vehicles to protect their lives. Corresponding Author: To contact the corresponding author, Jingzhen Yang, PhD, MPH, email ginger.yang@nationwidechildrens.org. To access the embargoed study: Visit our For The Media website ...

Reporting and representation of race and ethnicity in clinical trials of pharmacotherapy for mental disorders

2025-05-07
About The Study: The findings of this meta-analysis suggest that differences in reporting race and ethnicity across geographic locations and underrepresentation of certain racial and ethnic groups in U.S.-based randomized clinical trials highlight the need for international guidelines to ensure equitable recruitment and reporting in clinical trials.  Corresponding Author: To contact the corresponding author, Alessio Bellato, PhD, email a.bellato@soton.ac.uk. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (10.1001/jamapsychiatry.2025.0666) Editor’s ...

Clinical and neuropathological evaluations of the New Brunswick neurological syndrome of unknown cause

2025-05-07
About The Study: There was no evidence supporting a diagnosis of neurological syndrome of unknown cause (NSUC) in this cohort. The data inclusive of independent examinations and neuropathology strongly supported the presence of several neurodegenerative and non-neurodegenerative conditions. Unfounded concerns that a potentially fatal mystery disease, possibly induced by an environmental toxin, is causing the patients’ neurological symptoms has been amplified in traditional and social media. Second, independent clinical evaluations ...

Childhood brain tumors develop early in highly specialized nerve cells

2025-05-07
Medulloblastoma is one of the most common malignant tumors of the central nervous system (CNS) in children and adolescents. It develops in the area of the cerebellum, which is responsible for movement coordination, among other things. Medulloblastomas enlarge rapidly, often grow into surrounding tissue and can also form metastases. The wide variety of this tumor group also makes it difficult to find the right treatment. A team of researchers at the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ) and Heidelberg University ...

A new class of molecules against cancer cells refractory to standard treatments

2025-05-07
Current anticancer treatments essentially target the primary tumour cells that proliferate quickly, but do not effectively eliminate specific cancer cells able to adapt to existing treatments and which exhibit high metastatic potential1. Yet metastases are responsible for 70% of cancer deaths. A French research team from Institut Curie, the CNRS and Inserm has just developed a new class of small molecules that bring about the destruction of cell membranes, and hence triggers cell death. Led by scientists at the Laboratory of Biomedicine (Institut Curie/CNRS/Inserm)2, ...

LAST 30 PRESS RELEASES:

What can polymers teach us about curing Alzheimer's disease?

Lead-free alternative discovered for essential electronics component

BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders

Skin cancer cluster found in 15 Pennsylvania counties with or near farmland

For platforms using gig workers, bonuses can be a double-edged sword

Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon

New study reveals key role of inflammasome in male-biased periodontitis

MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer

Donors enable record pool of TPDA Awards to Neuroscience 2025

Society for Neuroscience announces Gold Sponsors of Neuroscience 2025

The world’s oldest RNA extracted from woolly mammoth

Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show

Reading a quantum clock costs more energy than running it, study finds

Early MMR vaccine adoption during the 2025 Texas measles outbreak

Traces of bacteria inside brain tumors may affect tumor behavior

Hypertension affects the brain much earlier than expected

Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio

Drift logs destroying intertidal ecosystems

New test could speed detection of three serious regional fungal infections

New research on AI as a diagnostic tool to be featured at AMP 2025

New test could allow for more accurate Lyme disease diagnosis

New genetic tool reveals chromosome changes linked to pregnancy loss

New research in blood cancer diagnostics to be featured at AMP 2025

Analysis reveals that imaging is overused in diagnosing and managing the facial paralysis disorder Bell’s palsy

Research progress on leptin in metabolic dysfunction-associated fatty liver disease

Fondazione Telethon announces CHMP positive opinion for Waskyra™, a gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS)

Vaccine Innovation Center, Korea University College of Medicine hosts an invited training program for Ethiopian Health Ministry officials

FAU study finds small group counseling helps children thrive at school

Research team uncovers overlooked layer of DNA that may shape disease risk

Study by Incheon National University could transform skin cancer detection with near-perfect accuracy

[Press-News.org] Paper sensors and smartphone app monitor personal smoke exposure